122 related articles for article (PubMed ID: 29406601)
1. The keratin 16 null phenotype is modestly impacted by genetic strain background in mice.
Zieman A; Coulombe PA
Exp Dermatol; 2018 Jun; 27(6):672-674. PubMed ID: 29406601
[TBL] [Abstract][Full Text] [Related]
2. Altered keratinocyte differentiation is an early driver of keratin mutation-based palmoplantar keratoderma.
Zieman AG; Poll BG; Ma J; Coulombe PA
Hum Mol Genet; 2019 Jul; 28(13):2255-2270. PubMed ID: 31220272
[TBL] [Abstract][Full Text] [Related]
3. Keratin 16-null mice develop palmoplantar keratoderma, a hallmark feature of pachyonychia congenita and related disorders.
Lessard JC; Coulombe PA
J Invest Dermatol; 2012 May; 132(5):1384-91. PubMed ID: 22336941
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress and dysfunctional NRF2 underlie pachyonychia congenita phenotypes.
Kerns ML; Hakim JM; Lu RG; Guo Y; Berroth A; Kaspar RL; Coulombe PA
J Clin Invest; 2016 Jun; 126(6):2356-66. PubMed ID: 27183391
[TBL] [Abstract][Full Text] [Related]
5. Pathophysiology of pachyonychia congenita-associated palmoplantar keratoderma: new insights into skin epithelial homeostasis and avenues for treatment.
Zieman AG; Coulombe PA
Br J Dermatol; 2020 Mar; 182(3):564-573. PubMed ID: 31021398
[TBL] [Abstract][Full Text] [Related]
6. Building models for keratin disorders.
Koster MI
J Invest Dermatol; 2012 May; 132(5):1324-6. PubMed ID: 22499036
[TBL] [Abstract][Full Text] [Related]
7. A new KRT16 mutation associated with a phenotype of pachyonychia congenita.
Paris F; Hurtado C; Azón A; Aguado L; Vizmanos JL
Exp Dermatol; 2013 Dec; 22(12):838-9. PubMed ID: 24118415
[TBL] [Abstract][Full Text] [Related]
8. Sexual Dimorphism in Response to an NRF2 Inducer in a Model for Pachyonychia Congenita.
Kerns ML; Hakim JMC; Zieman A; Lu RG; Coulombe PA
J Invest Dermatol; 2018 May; 138(5):1094-1100. PubMed ID: 29277538
[TBL] [Abstract][Full Text] [Related]
9. Collapse of the keratin filament network through the expression of mutant keratin 6c observed in a case of focal plantar keratoderma.
Kubo A; Oura Y; Hirano T; Aoyama Y; Sato S; Nakamura K; Takae Y; Amagai M
J Dermatol; 2013 Jul; 40(7):553-7. PubMed ID: 23662636
[TBL] [Abstract][Full Text] [Related]
10. Identification of clinically useful predictive genetic variants in pachyonychia congenita.
Samuelov L; Sarig O; Adir N; Pavlovsky M; Smith FJ; Schwartz J; Hansen CD; Sprecher E
Clin Exp Dermatol; 2021 Jul; 46(5):867-873. PubMed ID: 33486795
[TBL] [Abstract][Full Text] [Related]
11. Keratins K2 and K10 are essential for the epidermal integrity of plantar skin.
Fischer H; Langbein L; Reichelt J; Buchberger M; Tschachler E; Eckhart L
J Dermatol Sci; 2016 Jan; 81(1):10-6. PubMed ID: 26603179
[TBL] [Abstract][Full Text] [Related]
12. Two novel de novo mutations of KRT6A and KRT16 genes in two Chinese pachyonychia congenita pedigrees with fissured tongue or diffuse plantar keratoderma.
Du ZF; Xu CM; Zhao Y; Liu WT; Chen XL; Chen CY; Fang H; Ke HP; Zhang XN
Eur J Dermatol; 2012; 22(4):476-80. PubMed ID: 22668561
[TBL] [Abstract][Full Text] [Related]
13. Pachyonychia congenita patients with mutations in KRT6A have more extensive disease compared with patients who have mutations in KRT16.
Spaunhurst KM; Hogendorf AM; Smith FJ; Lingala B; Schwartz ME; Cywinska-Bernas A; Zeman KJ; Tang JY
Br J Dermatol; 2012 Apr; 166(4):875-8. PubMed ID: 22098151
[TBL] [Abstract][Full Text] [Related]
14. A large mutational study in pachyonychia congenita.
Wilson NJ; Leachman SA; Hansen CD; McMullan AC; Milstone LM; Schwartz ME; McLean WH; Hull PR; Smith FJ
J Invest Dermatol; 2011 May; 131(5):1018-24. PubMed ID: 21326300
[TBL] [Abstract][Full Text] [Related]
15. Novel keratin 16 mutations and protein expression studies in pachyonychia congenita type 1 and focal palmoplantar keratoderma.
Smith FJ; Fisher MP; Healy E; Rees JL; Bonifas JM; Epstein EH; Tan EM; Uitto J; McLean WH
Exp Dermatol; 2000 Jun; 9(3):170-7. PubMed ID: 10839714
[TBL] [Abstract][Full Text] [Related]
16. A role for keratins in supporting mitochondrial organization and function in skin keratinocytes.
Steen K; Chen D; Wang F; Majumdar R; Chen S; Kumar S; Lombard DB; Weigert R; Zieman AG; Parent CA; Coulombe PA
Mol Biol Cell; 2020 May; 31(11):1103-1111. PubMed ID: 32213122
[TBL] [Abstract][Full Text] [Related]
17. Keratin K6c mutations cause focal palmoplantar keratoderma.
Wilson NJ; Messenger AG; Leachman SA; O'Toole EA; Lane EB; McLean WH; Smith FJ
J Invest Dermatol; 2010 Feb; 130(2):425-9. PubMed ID: 19609311
[TBL] [Abstract][Full Text] [Related]
18. A review of the clinical phenotype of 254 patients with genetically confirmed pachyonychia congenita.
Eliason MJ; Leachman SA; Feng BJ; Schwartz ME; Hansen CD
J Am Acad Dermatol; 2012 Oct; 67(4):680-6. PubMed ID: 22264670
[TBL] [Abstract][Full Text] [Related]
19. Keratin 16 regulates innate immunity in response to epidermal barrier breach.
Lessard JC; Piña-Paz S; Rotty JD; Hickerson RP; Kaspar RL; Balmain A; Coulombe PA
Proc Natl Acad Sci U S A; 2013 Nov; 110(48):19537-42. PubMed ID: 24218583
[TBL] [Abstract][Full Text] [Related]
20. A novel frameshift mutation in keratin 16 underlies pachyonychia congenita with focal palmoplantar keratoderma.
Cao LH; Luo Y; Wen W; Liu WL; Jiang L; Chen C; Ji CY; Zhang X
Br J Dermatol; 2011 Nov; 165(5):1145-7. PubMed ID: 21668426
[No Abstract] [Full Text] [Related]
[Next] [New Search]
